The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular subtype to predict pathologic complete response in HER2-positive breast cancer in the I-SPY2 trial.
 
Alexandra Thomas
Stock and Other Ownership Interests - Bristol-Myers Squibb; Doximity; Gilead Sciences; Johnson & Johnson (I); Pfizer
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; Genentech; Lilly
Research Funding - Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Up-to-Date Royalties (I)
 
Amy Sanders Clark
Honoraria - Siemens
Consulting or Advisory Role - Novartis
Research Funding - Lilly (Inst); Novartis (Inst); Seagen
 
Christina Yau
No Relationships to Disclose
 
Denise M. Wolf
No Relationships to Disclose
 
Laura van 't Veer
Employment - Agendia
Stock and Other Ownership Interests - Agendia
 
Emily H. Douglas
No Relationships to Disclose
 
Amy Jo Chien
Honoraria - bioTheranostics; sanofi
Consulting or Advisory Role - Novartis; Seagen
Research Funding - Amgen (Inst); Merck (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
Laura Ann Huppert
No Relationships to Disclose
 
Hope S. Rugo
Honoraria - Mylan; Puma Biotechnology; Samsung Bioepis
Consulting or Advisory Role - Napo Pharmaceuticals
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
 
Rebecca Arielle Shatsky
Honoraria - Horizon CME; OncoSec; Relevate Health; SOTERIA Precision Medicine; The Dedham Group
Consulting or Advisory Role - OncoSec; SOTERIA Precision Medicine; The Dedham Group
Speakers' Bureau - Horizon CME
Research Funding - CytomX Therapeutics (Inst); Genentech (Inst); Merck (Inst); OncoSec (Inst); Oncternal Therapeutics (Inst); Phoenix Molecular Designs (Inst)
 
Claudine Isaacs
Consulting or Advisory Role - AstraZeneca/MedImmune; bioTheranostics; Eisai; Genentech/Roche; Ion Solutions; Novartis; Pfizer; Puma Biotechnology; Sanofi/Aventis; Seagen
Research Funding - Merck (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Other Relationship - Side-Out Foundation
 
Donald A. Berry
Other Relationship - Donald Berry is co-owner of Berry Consultants, LLC, a company that designs adaptive Bayesian clinical trials (including I-SPY 2) for pharmaceutical and medical device companies, NIH cooperative groups, patient advocacy groups, and international consortia.
 
Douglas Yee
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Martell diagnostic
Research Funding - Boehringer Ingelheim
 
Angela DeMichele
Research Funding - Calithera Biosciences (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative